HEPA
Hepion Pharmaceuticals
HEPA
HEPA
Delisted
HEPA was delisted on the 12th of May, 2025.
4 hedge funds and large institutions have $1.3M invested in Hepion Pharmaceuticals in 2018 Q1 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, reducing their positions, and 1 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
4
Holders Change
-1
Holders Change %
-20%
% of All Funds
0.09%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
–
Reduced
–
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
No buyers this quarter
Top Sellers
| 1 |
AFM
Anson Funds Management
Dallas,
Texas
|
-$446K |
| 2 |
JPMorgan Chase & Co
New York
|
-$72K |
| 3 |
VF
Virtu Financial
New York
|
-$65K |
| 4 |
PFS
Prospera Financial Services
Dallas,
Texas
|
-$57K |
| 5 |
CS
Credit Suisse
Zurich,
Switzerland
|
-$54K |
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
26
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
| – | -$8K | – | – |
|
|
CC
27
Cornerstone Capital
Palo Alto,
California
| – | -$10K | – | – |
|
|
ISL
28
Ingalls & Snyder LLC
New York
| – | -$5K | – | – |
|
|
PIA
29
Phoenix Investment Adviser
New York
| – | -$36K | – | – |
|